Dose comparison of robustly optimized intensity modulated proton therapy (IMPT) vs IMRT and VMAT photon plans for testicular seminoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dose comparison of robustly optimized intensity modulated proton therapy (IMPT) vs IMRT and VMAT photon plans for testicular seminoma

Published:2023-09-08 Issue:10 Volume:62 Page:1222-1229
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Rønde Heidi S.¹^ORCID,Kronborg Camilla¹,Høyer Morten¹^ORCID,Hansen Jolanta²,Bak Malene Eppler³^ORCID,Agergaard Søren Nielsen⁴,Als Anne Birgitte²,Agerbæk Mads²,Lauritsen Jakob³,Meidahl Petersen Peter³,Dysager Lars⁴,Kallehauge Jesper F.¹^ORCID

Affiliation:

1. Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark

2. Department of Oncology, Aarhus University Hospital, Aarhus, Denmark

3. Department of Oncology, Rigshospitalet, Copenhagen, Denmark

4. Department of Oncology, Odense University Hospital, Odense, Denmark

Publisher

Medical Journals Sweden AB

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2023.2254925

Reference28 articles.

1. Global patterns in testicular cancer incidence and mortality in 2020

2. Adjuvant radiation therapy for early stage seminoma: Proton versus photon planning comparison and modeling of second cancer risk

3. Surveillance versus adjuvant radiotherapy for patients with high-risk stage I seminoma

4. A Nationwide Cohort Study of Stage I Seminoma Patients Followed on a Surveillance Program

5. Performance Characteristics of Clinical Staging Modalities for Early Stage Testicular Germ Cell Tumors: A Systematic Review

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Iodine‑125 seeds combined with carboplatin in the treatment of retroperitoneal metastatic seminoma: A case report and literature review;Oncology Letters;2024-02-15

2. New technologies from bench to bedside – report from the Nordic association for clinical physics 2023 symposium;Acta Oncologica;2023-10-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3